Polyrizon Ltd. (NasdaqCM: PLRZ)
Health Care · Biotechnology · IL
$10.00
+11.26% today · +43.7% 1Y
Polyrizon Ltd. (NasdaqCM: PLRZ) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.29M and employs 6 people.
Over the last twelve months the share price has gained 43.7%, trading between 2.88 and 18.20.
Tweenvest scores Polyrizon Ltd. across four factors: quality 44/100, value 30/100. Its strongest factor is quality.
PLRZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.29M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.13
- Dividend yield
- —
- Beta (5Y)
- -1.15
- 52-week high
- $18.20
- 52-week low
- $2.88
- Avg volume (3M)
- —
- Shares outstanding
- 2.43M
- Employees
- 6
- Next earnings
- —
About Polyrizon Ltd.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
- ISIN
- IL0011814113
- Founded
- 2005
- Listed since
- Oct 29, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Seres Therapeutics, Inc.NasdaqGS: MCRB | $24.71M | $2.46 | -9.23% |
| Lukas Biomedical Inc.TPEX: 6814 | $24.52M | NT$19.00 | +2.70% |
| Original BioMedicals Co., Ltd.TPEX: 6483 | $24.50M | NT$11.90 | +3.93% |
| Ribomic Inc.TSE: 4591 | $24.36M | ¥68.00 | -4.23% |
| Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH | $24.20M | $5.08 | -4.69% |
| Eutilex.Co.,LtdKOSDAQ: A263050 | $24.14M | ₩— | — |
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
| Xbrane Biopharma AB (publ)OM: XBRANE | $23.72M | Skr11.40 | -18.28% |
Figures last refreshed Oct 18, 2026.